Cargando…
Targeted Theranostic Nanoparticles for Brain Tumor Treatment
The poor prognosis and rapid recurrence of glioblastoma (GB) are associated to its fast-growing process and invasive nature, which make difficult the complete removal of the cancer infiltrated tissues. Additionally, GB heterogeneity within and between patients demands a patient-focused method of tre...
Autores principales: | Mendes, Maria, Sousa, João José, Pais, Alberto, Vitorino, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321593/ https://www.ncbi.nlm.nih.gov/pubmed/30304861 http://dx.doi.org/10.3390/pharmaceutics10040181 |
Ejemplares similares
-
Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
por: Basso, João, et al.
Publicado: (2018) -
The Role of Magnetic Nanoparticles in Cancer Nanotheranostics
por: Ferreira, Maria, et al.
Publicado: (2020) -
A Stepwise Framework for the Systematic Development of Lipid Nanoparticles
por: Basso, João, et al.
Publicado: (2022) -
A two-pronged approach against glioblastoma: drug repurposing and nanoformulation design for in situ-controlled release
por: Mendes, Maria, et al.
Publicado: (2023) -
MRI-traceable theranostic nanoparticles for targeted cancer treatment
por: Anani, Tareq, et al.
Publicado: (2021)